|New Threads Only:|
|New Threads & Replies:|
Forum List » Business News and Headlines|
SEC Filings, Earing Reports, Press Releases
Valeant Pharmaceuticals International (VRX) COO, Biovail Labs.Intl SRL Michel Chouinard sells 134,908 Shares
Posted by: insider (IP Logged)
Date: December 1, 2010 05:20PM
COO, Biovail Labs.Intl SRL of Valeant Pharmaceuticals International (VRX) Michel Chouinard sells 134,908 shares of VRX on 11/29/2010 at an average price of $25.19 a share.
Valeant Pharmaceuticals International has a market cap of $7.76 billion; its shares were traded at around $25.87 with a P/E ratio of 22.3 and P/S ratio of 9.5. The dividend yield of Valeant Pharmaceuticals International stocks is 1.5%. Valeant Pharmaceuticals International had an annual average earning growth of 13.7% over the past 5 years.
VRX is in the portfolios of Francis Chou of Chou Associates Management Inc., Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, John Griffin of Blue Ridge Capital, Private Capital of Private Capital Management, Andreas Halvorsen of Viking Global Investors LP, John Hussman of Hussman Economtrics Advisors, Inc., Jim Simons of Renaissance Technologies LLC, Jean-Marie Eveillard of First Eagle Investment Management, LLC, NWQ Managers of NWQ Investment Management Co.
Directors and Officers Recent Trades:
Stocks Discussed: VRX,